soul trial oral semaglutide cardiovascular outcomes results 2025 nejm (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Effects of Semaglutide on Heart

E' commercializzato in Italia dall'azienda Novo Nordisk S.p.A

The rats were administered IPA, GHRP-6, growth hormone (GH), or a vehicle for 12 weeks

The majority of semaglutide users continue losing 0.5 to 1.5 pounds per week at maintenance, though individual results vary significantly based on adherence, diet, activity, and genetic factors

Thnh phn Semaglutide 2.4 mg (ngun gc r-DNA) Cng dng H tr gim cn, kim sot bo ph hoc tha cn (c bit ngi c BMI 30, hoc BMI 27 km bnh l lin quan n cn nng nh tiu ng type 2, cao huyt p, ri lon m mu)

Peptides help your body focus on burning fat while maintaining muscle, supporting both metabolic health and physical strength